Lori Murray
Investor Relations Contact bei RUBIUS THERAPEUTICS
Profil
Lori Murray is currently the Chief Corporate Affairs Officer at Rubius Therapeutics, Inc. She previously worked at Onyx Pharmaceuticals, Inc. as the Head-Media Relations from 2009 to 2015.
Ms. Murray completed her undergraduate degree at the University of California, Davis and holds an MBA from the University of San Francisco.
Aktive Positionen von Lori Murray
| Unternehmen | Position | Beginn |
|---|---|---|
| RUBIUS THERAPEUTICS | Investor Relations Contact | 01.06.2018 |
Ehemalige bekannte Positionen von Lori Murray
| Unternehmen | Position | Ende |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | 01.12.2015 |
Ausbildung von Lori Murray
| University of California, Davis | Undergraduate Degree |
| University of San Francisco | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
